Related references
Note: Only part of the references are listed.Can ACEIs and ARBs be safely continued in COVID-19:- The Evidence is here at Last!
Uma Velupandian
HEART VIEWS (2021)
Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
Jordana B. Cohen et al.
LANCET RESPIRATORY MEDICINE (2021)
COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection
Katarzyna Kotfis et al.
PHARMACEUTICALS (2021)
Hypothiocyanite and Hypothiocyanite/Lactoferrin Mixture Exhibit Virucidal Activity In Vitro against SARS-CoV-2
Luca Cegolon et al.
PATHOGENS (2021)
Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy
Emanuel Wyler et al.
ISCIENCE (2021)
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
Yuyang Lei et al.
CIRCULATION RESEARCH (2021)
Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation
Mart M. Lamers et al.
ELIFE (2021)
The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19
Kun Li et al.
MBIO (2021)
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
D. A. Leach et al.
NATURE COMMUNICATIONS (2021)
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
Axel Bauer et al.
LANCET RESPIRATORY MEDICINE (2021)
COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension A Meta-Analysis
Xiaoming Guo et al.
HYPERTENSION (2020)
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
Gian Paolo Rossi et al.
ELIFE (2020)
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lei Fang et al.
LANCET RESPIRATORY MEDICINE (2020)
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo et al.
JAMA CARDIOLOGY (2020)
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Shaobo Shi et al.
JAMA CARDIOLOGY (2020)
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
Giuseppe Mancia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner
Mizuki Yamamoto et al.
VIRUSES-BASEL (2020)
Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients
Zhiyong Wu et al.
CRITICAL CARE (2020)
A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial
Jon-David Schwalm et al.
LANCET (2019)
ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY
Steven J. Forrester et al.
PHYSIOLOGICAL REVIEWS (2018)
Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein
Jovan Nikolic et al.
NATURE COMMUNICATIONS (2018)
Mechanism of membrane fusion induced by vesicular stomatitis virus G protein
Irene S. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Angiotensin-Converting Enzyme Inhibitors and Bacterial Pneumonia in Patients with Parkinson Disease
Han-Cheng Wang et al.
MOVEMENT DISORDERS (2015)
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Chen-Jei Tai et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems
Alan Baer et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
The past, present and future of renin-angiotensin aldosterone system inhibition
Robert J. Mentz et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients
Chia-Lin Liu et al.
JOURNAL OF HYPERTENSION (2012)
Generation of a dual-functional split-reporter protein for monitoring membrane fusion using self-associating split GFP
Hirohito Ishikawa et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
Daniel Caldeira et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon
Marianne Berger Rentsch et al.
PLOS ONE (2011)
Conformational Changes of the HIV-1 Envelope Protein during Membrane Fusion Are Inhibited by the Replacement of Its Membrane-spanning Domain
Naoyuki Kondo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines
Michael A. Whitt
JOURNAL OF VIROLOGICAL METHODS (2010)
A rapid and efficient method for studies of virus interaction at the host cell surface using enteroviruses and real-time PCR
Nina Jonsson et al.
VIROLOGY JOURNAL (2009)
Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway
Vijay Koka et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia
E. M. Mortensen et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats
Yoshiyu Takeda et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats
M Igase et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Myocardial infarction increases ACE2 expression in rat and humans
LM Burrell et al.
EUROPEAN HEART JOURNAL (2005)
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors
Y Ishiyama et al.
HYPERTENSION (2004)
Share Paper
